Brown & Brown Posts $1.06 EPS on Record $1.9B Revenue, But Organic Growth Stalls
Insurance brokerage giant Brown & Brown (NYSE: BRO) delivered mixed first quarter 2026 results, with acquisition-fueled revenue growth of 35.4% to $1.9 billion overshadowed by flat organic revenue performance and declining earnings per share.
The Daytona Beach-based company reported diluted earnings per share of $1.06 for the quarter ended March 31, 2026, down 7.8% from $1.15 in the prior year period. On an adjusted basis, which excludes acquisition costs and amortization expenses, diluted EPS rose 7.8% to $1.39 from $1.29.
Key Numbers
Brown & Brown's total revenues surged to $1.901 billion from $1.404 billion a year earlier, a gain of $497 million or 35.4%. However, this impressive headline growth was entirely driven by acquisitions, as organic revenue remained completely flat at 0.0% growth year-over-year.
The company's core metric of commissions and fees reached $1.880 billion, up from $1.385 billion. When including contingent commissions, organic revenue managed modest growth of 2.2%, suggesting the underlying business faced significant headwinds despite the acquisition activity.
Net income attributable to the company increased 28.7% to $426 million from $331 million. The income before income taxes margin compressed to 28.0% from 30.4% in the prior year, reflecting integration costs from the substantial acquisition activity.
EBITDAC-Adjusted, a key profitability metric that excludes interest, taxes, depreciation, amortization, and change in acquisition earn-outs, rose 36.6% to $731 million. The EBITDAC-Adjusted margin expanded slightly to 38.5% from 38.1%.
What Management Said
CEO J. Powell Brown offered a notably brief assessment of the quarter's performance, stating only that "Our teammates continue to deliver for our customers in a challenging growth environment."
This terse commentary acknowledges the difficult operating conditions facing the insurance brokerage industry, where organic growth has become increasingly elusive despite robust merger and acquisition activity.
The company's aggressive acquisition strategy is evident in the numbers, with $435 million of revenue growth coming from acquisitions during the quarter. This represents nearly all of the revenue increase, highlighting Brown & Brown's dependence on M&A to drive expansion in a mature market.
Management also announced a quarterly dividend of $0.165 per share, payable on May 20, 2026, to shareholders of record on May 11, 2026, maintaining the company's commitment to returning capital to shareholders despite the growth challenges.
What to Watch
The most critical metric for investors to monitor is organic revenue growth, which stalled completely in Q1 2026. This flat performance raises questions about the sustainability of Brown & Brown's growth strategy and whether the company can reignite internal expansion beyond acquisitions.
Integration costs remain a key concern, with acquisition and integration expenses reaching $26 million in the quarter. The company recorded $0.06 per share in acquisition-related costs, suggesting continued pressure on profitability as Brown & Brown digests its recent deals.
The balance sheet shows long-term debt of $6.584 billion, down from $6.894 billion at year-end 2025, but the current portion of long-term debt jumped to $1.238 billion from $719 million, indicating significant near-term refinancing needs.
Operating cash flow remained healthy at $262 million, up from $213 million in the prior year, providing flexibility for continued acquisitions and dividend payments. However, the company's ability to generate organic growth will ultimately determine whether the acquisition strategy creates long-term shareholder value.
With employee compensation and benefits surging to $907 million from $683 million year-over-year, investors should watch whether Brown & Brown can achieve operating leverage from its expanded scale or if margin pressure will persist.
The insurance brokerage sector faces ongoing challenges from market saturation and pricing pressure, making Brown & Brown's next quarter critical for demonstrating whether the company can restart organic growth while successfully integrating its recent acquisitions.
*Source: Brown & Brown Q1 2026 Form 8-K filing with the SEC*
— StockCliff Research